Ainsley Ross

Brigham and Women's Hospital

Boston, Massachusetts - 02115 (617-732-6237)

CLINICAL TRIALS 1
CONDITIONS5
INTERVENTIONS2
SINCE2008

D-dimer to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped at 3 Months

September 2008 - August 2012

Thrombosis

Venous Thrombosis

Embolism

Pulmonary Embolism

Venous Thromboembolism

Discontinue Anticoagulant Therapy (Negative D-Dimer)

Continue On Anticoagulant Therapy (Positive D-Dimer)

Learn about TrialX Patient Recruitment services

Massimo Loda, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute

Suzanne Shusterman

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Childrens Hospital Boston, Dana-Farber Cancer Institute. Children's Hospital Boston

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute Dana Farber / Brigham and Women's Cancer Center Dana-Farber Cancer Institute, Center for Neuro-Oncology Dana-Farber Cancer Instiute

Lewis B. Silverman, MD

Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Dana-Farber Cancer Institute and Children's Hospital Dana Faber Cancer Institute, Children's Hospital, Dept. of Pediatric Oncology Children's Hospital Boston Dana-Farber Cancer Institute

Ainsley Ross

Brigham and Women's Hospital

Massimo Loda, MD

Suzanne Shusterman

Patrick Y. Wen, MD

Lewis B. Silverman, MD

Kay Kehoe, Coordinator

Jennifer Brown, MD

Rachel A. Freedman

Edwin P. Alyea, MD

F. Stephen Hodi, MD

Beth A. Overmoyer, MD, FACP